Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Hypertrophy Of Nigral Neurons In Torsin1A Deletion (DYT1) Carriers Manifesting Dystonia.

D. Iacono, Maria Geraci-Erck, H. Peng, Marcie L. Rabin, R. Kurlan
Published 2019 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
OBJECTIVE To individuate morphometric changes and prevalent types of intraneuronal inclusions in nigral neurons of DYT1 dystonia autopsy-brains. METHODS Using precise methods of quantification, such as unbiased stereology, we measured cellular and subcellular volumes of neuromelanin-containing (pigmented) neurons in the substantia nigra (SN) of DYT1 carriers with and without manifestation of generalized dystonia (manif-DYT1 and non-manif-DYT1, respectively), non-DYT1 carriers manifesting generalized dystonia (manif-non-DYT1) patients, and age-matched control subjects (controls). A total of four DYT1 carriers (two manif-DYT1 and two non-manif-DYT1), six manif-non-DYT1 carriers, and six controls autopsy-brains were available for these neuropathological-morphometric analyses. The search of brain lesions was performed for: tau neurofibrillary tangles and neurites, extracellular β-amyloid deposits, Lewy bodies and neurites, TorsinA, Laminin A + C, Ubiquitin, p62, pTDP43 intraneuronal inclusions; and Negri, Bunina, Hirano, Marinesco, Nissl, and Buscaino bodies. RESULTS An increased mean cell body, nuclear, and nucleolar volume of nigral neurons in manif-DYT1 vs. non-manif-DYT1 (p < 0.0001), manif-non-DYT1 (p < 0.0001), and controls (p < 0.00001) was found. Increased nuclear and nucleolar volumes in manif-non-DYT1 vs. controls were also found. None of the considered possible intraneuronal lesions were more frequent or prevalent in nigral neurons of manif-DYT1 vs. all the other groups. CONCLUSIONS Unbiased stereology-based measurements of nigral neurons enlargement in manif-DYT1 in the absence of intraneuronal inclusions or neurodegenerative processes, is novel. These findings suggest distinct pathogenetic mechanisms between manif-DYT1 vs. non-manif-DYT1 and manif-non-DYT1 dystonia, especially in terms of possible nigral dopaminergic abnormalities. These data could open new pathophysiologic views on specific dopamino-associated pathomechanisms related to the clinical manifestation of generalized dystonia.
This paper references
10.1007/s00401-008-0352-8
Morphometry of the human substantia nigra in ageing and Parkinson’s disease
G. Rudow (2008)
10.1016/S0969-9961(02)00010-4
TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion
K. Rostásy (2003)
10.1002/mds.25475
Phenomenology and classification of dystonia: A consensus update
Alberto Albanese (2013)
10.1016/j.nbd.2010.11.015
Molecular pathways in dystonia
D. C. Bragg (2011)
10.7916/D8T72G9G
Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses
D. Iacono (2015)
10.1212/01.wnl.0000302175.76229.f0
Neuropathology of primary adult-onset dystonia
J. Holton (2008)
10.1093/cercor/bhu104
Thalamocortical Connectivity Correlates with Phenotypic Variability in Dystonia.
A. Vo (2015)
10.1007/s11910-013-0401-0
Understanding the Anatomy of Dystonia: Determinants of Penetrance and Phenotype
Renata P. Lerner (2013)
10.1136/jnnp.54.1.30
The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.
B. Pakkenberg (1991)
10.1186/s40478-014-0159-x
Neuropathological features of genetically confirmed DYT1 dystonia: investigating disease-specific inclusions
R. Paudel (2014)
TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.
T. Nagatsu (1964)
10.3109/10409238.2015.1091804
Torsins: not your typical AAA+ ATPases
April E Rose (2015)
10.1124/jpet.117.246348
Dopamine Receptor Agonist Treatment of Idiopathic Dystonia: A Reappraisal in Humans and Mice
Xueliang Fan (2018)
10.1016/B978-0-12-394395-8.00002-5
The genetics of dystonias.
M. LeDoux (2012)
10.1186/s40478-015-0183-5
Neuronal nucleus and cytoplasm volume deficit in children with autism and volume increase in adolescents and adults
J. Wegiel (2015)
10.1111/j.1365-2990.2012.01298.x
Review: Genetics and neuropathology of primary pure dystonia
R. Paudel (2012)
10.1016/S0165-3806(01)00223-1
Soma size of substantia nigra neurons increases after a prenatal neocortical lesion in cats.
L. Loopuijt (2001)
10.1111/j.1699-0463.1988.tb00954.x
The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis
H. Gundersen (1988)
10.1002/mds.25244
The prevalence of primary dystonia: A systematic review and meta‐analysis
T. Steeves (2012)
10.1016/j.nbd.2012.04.015
Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA
G. Sciamanna (2012)
10.1038/ng0997-40
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
L. Ozelius (1997)
10.1523/JNEUROSCI.21-13-04789.2001
Neuronal Hypertrophy in the Neocortex of Patients with Temporal Lobe Epilepsy
S. Bothwell (2001)
10.1002/mds.21160
Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers
M. Edwards (2006)
10.1523/JNEUROSCI.0407-13.2013
Abnormal Striatal Dopaminergic Neurotransmission during Rest and Task Production in Spasmodic Dysphonia
K. Simonyan (2013)
10.1002/ana.20225
Brainstem pathology in DYT1 primary torsion dystonia
K. S. P. McNaught (2004)
10.1073/pnas.1016445108
Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice
A. Ulug (2011)
10.1016/j.nbd.2012.05.009
Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia
ChangHyun Song (2012)
10.1016/j.expneurol.2012.11.019
Neuropathology of cervical dystonia
C. Prudente (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar